Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation

David-Dan Nguyen,Tiange Li,Roseanne Ferreira,Mohamad Baker Berjaoui,Anna-Lisa V. Nguyen,Bilal Chughtai,Kevin C. Zorn,Naeem Bhojani,Dean Elterman
DOI: https://doi.org/10.1038/s41391-023-00669-z
2023-04-21
Prostate Cancer and Prostatic Diseases
Abstract:Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting men and can present with bothersome lower urinary tract symptoms (LUTS). Historically, transurethral resection of the prostate (TURP) has been considered the gold standard in the treatment of LUTS due to BPH. However, TURP and other traditional options for the surgical management of LUTS secondary to BPH are associated with high rates of sexual dysfunction. In the past decade, several novel technologies, including Aquablation therapy, convective water vapor therapy (Rezum), and transperineal prostate laser ablation (TPLA), have demonstrated promising evidence to be safe and effective while preserving sexual function.
oncology,urology & nephrology
What problem does this paper attempt to address?